Citation Impact
Citing Papers
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Insulin-Like Growth Factor 2 Promotes Osteogenic Cell Differentiation in the Parthenogenetic Murine Embryonic Stem Cells
2011
Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters
2017 Standout
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
2009 StandoutNobel
Visceral protein status and caloric intake in exercising versus nonexercising individuals with end-stage renal disease
1999 Standout
Oral Phosphate Binders in Patients with Kidney Failure
2010
Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability
2010
Advanced oxidation protein products as a novel marker of oxidative stress in uremia
1996 Standout
A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia
1995
Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy
1992
Circulating biochemical markers of bone remodeling in uremic patients
1999
Vitamin D Metabolism, Mechanism of Action, and Clinical Applications
2014 Standout
Risk Factors for Hip Fracture in Hemodialysis Patients
2002
Renal and Extrarenal Effects of Gum Arabic (Acacia Senegal) - What Can be Learned from Animal Experiments?
2013 Standout
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
2004 Standout
Mortality in Dialysis Patients: Analysis of the Causes of Death
1991
Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease
2010 Standout
How to improve R&D productivity: the pharmaceutical industry's grand challenge
2010 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone
2000
The development of binary Mg–Ca alloys for use as biodegradable materials within bone
2008 Standout
Candidate Genes for Osteoporosis
2001
Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
2006 Standout
Hyperphosphataemia in Renal Failure
2003
Calcium kinetics and the long-term effects of lowering dialysate calcium concentration
1993
Recent advances in bone tissue engineering scaffolds
2012 Standout
Nutrition in Bone Health Revisited: A Story Beyond Calcium
2000
Calcium acetate versus calcium carbonate as oral phosphate binder in pediatric and adolescent hemodialysis patients
1996
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
2017 Standout
The therapeutic application of lanthanides
2006
Dose of Erythropoiesis-Stimulating Agents and Adverse Outcomes in CKD: A Metaregression Analysis
2012
Chronic Kidney Disease
2016 Standout
Relative in Vitro Efficacy of the Phosphate Binders Lanthanum Carbonate and Sevelamer Hydrochloride
2007 StandoutNobel
Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
2011
Magnesium in Man: Implications for Health and Disease
2014 Standout
Managing phosphate retention: is a change necessary?
2000
A comparative review of the efficacy and safety of established phosphate binders: calcium, sevelamer, and lanthanum carbonate
2007
The Tumor Lysis Syndrome
2011 Standout
Vitamin D and Immune Function
2013 Standout
Do Ketoanalogues Still Have a Role in Delaying Dialysis Initiation in CKD Predialysis Patients?
2013
Hypercholesterolaemia and vascular disease after transplantation
1991 StandoutNobel
Lipid abnormalities in uremia, dialysis, and transplantation
1981
Bioorthogonale Chemie – oder: in einem Meer aus Funktionalität nach Selektivität fischen
2009 StandoutNobel
Works of G. Asmus being referenced
The Treatment of Uraemic Hyperphosphataemia with Calcium Acetate and Calcium Carbonate: A Comparative Study
1991
A comparison of haemoglobin levels and doses in haemodialysis patients treated with subcutaneous or intravenous darbepoetin alfa: a German prospective, randomized, multicentre study
2008
Efficacy, Tolerability, and Safety of Lanthanum Carbonate in Hyperphosphatemia: A 6-Month, Randomized, Comparative Trial versus Calcium Carbonate
2005
Bone Fracture History and Prospective Bone Fracture Risk of Hemodialysis Patients are Related to Apolipoprotein E Genotype
1998
Chronic Hemofiltration
1978
The beneficial effect of ketoacids on serum phosphate and parathyroid hormone in patients with chronic uremia.
1988
Bone fracture risk in haemodialysis patients is related to apolipoprotein E (APOE) genotype, A modulator of vitamin k status
1996
Optimum dialysis treatment for patients over 60 years with primary renal disease. Survival data and clinical results from 242 patients treated either by haemodialysis or haemofiltration.
1985